Home/Pipeline/Diulcus®

Diulcus®

Diabetic Foot Ulcer (DFU)

MarketedActive (Marketing rights in India)

Key Facts

Indication

Diabetic Foot Ulcer (DFU)

Phase

Marketed

Status

Active (Marketing rights in India)

Company

Ipca Laboratories

About Ipca Laboratories

Ipca Laboratories is a mission-driven, fully integrated global pharmaceutical company dedicated to advancing healthcare through quality, affordable medicines. Its strategic achievements include establishing world-leading API manufacturing capabilities, securing approvals from stringent global regulators, and building a robust international footprint. The company's core strategy hinges on vertical integration for cost and supply chain control, therapeutic area dominance, and a growing R&D focus on novel drugs and biologics to drive future growth.

View full company profile

Therapeutic Areas

Anti-malarials Analgesics/Pain Anti-inflammatory Cardiovascular Anti-diabetics Anti-infectives Hair Care

Other Diabetic Foot Ulcer (DFU) Drugs

Drug	Company	Phase	Status
Galnobax®	NovaLead Pharma	Phase 3	Active